Equity Research · Thursday, October 1, 2026
CBRS Stock Analysis for October 2026
Cerebras Systems Inc. Class A Common Stock
Price at Analysis
1Y Price Target
$125.00
-29.6%
vs current price
Technical Setup
RSI 40 / bearish MACD
Support context: $160.81. Resistance context: $386.34.
Valuation Snapshot
P/E N/A (GAAP unprofitable, ~145x next-year est. earnings) / P/S ~47.7x 2026E sales (~$885M guide), 21.40x forward P/S
Market cap $42.20B; revenue ~$885M 2026 guidance (Q2 core $209.9M +103% YoY, GAAP $180.1M).
Risk Watch
Single-customer dependency
76% revenue from top 3, 80% backlog from OpenAI. Loss, delay, renegotiation, or OpenAI insourcing would erase growth story. Warrant amortization already caused GAAP sequential decline, showing accounting drag from customer incentives.
01 · Summary
Executive Summary
Cerebras Systems has real technology — wafer-scale WSE-3 with 150 patents, 103% YoY core revenue growth to $209.9M in Q2 2026, inference cloud up ~4x, and a $25.4B RPO anchored by a $20B+ OpenAI commitment plus AWS distribution. That backlog is 28x guided 2026 revenue of $880-890M and underpins the bull case for AI inference leadership in a $292B market by 2029. The stock has already been cut 54% from its $386.34 post-IPO high to $177.65, now sitting just 10.5% above its $160.81 low. At $42.2B market cap on <$1B in revenue, the market has started to price execution risk, but not enough. The core problem is conversion and concentration: Q3 core guidance of $214-216M is only 2-3% sequential growth, GAAP revenue actually fell sequentially to $180.1M on warrant amortization, GAAP net loss was $450.5M, gross margin compressed to ~40.6% heading to 38-40%, operating margin guided to -30%, FCF is -$680M TTM, and 76% of revenue comes from the top 3 customers with ~80% of backlog from OpenAI alone. Paying ~47x 2026 revenue and 21.4x forward sales and ~145x next year's estimated earnings for decelerating sequential growth, negative leverage, and single-customer dependency is unjustifiable. We are bearish — the RPO is an option on flawless capacity build-out, not revenue.
02 · Scenario Modeling
Price Targets
$125.00-29.6%
$140.00-21.2%
1-Year scenario price targets · Dashed line = current price
02 · Scenario Modeling
Scenario Analysis
| Scenario | 1Y Target | 1Y Growth | 3Y Target | 3Y Growth |
|---|---|---|---|---|
↑↑Hyper Bull | $320.00 | +80.1% | $550.00 | +209.6% |
↑Bull | $230.00 | +29.5% | $380.00 | +113.9% |
→Neutral | $185.00 | +4.1% | $250.00 | +40.7% |
↓Bear | $125.00 | -29.6% | $140.00 | -21.2% |
↓↓Hyper Bear | $60.00 | -66.2% | $45.00 | -74.7% |
03 · Fundamentals
Key Financial Metrics
- Earnings Per Share (EPS)
- N/A (negative)
- Beta
- N/A (recent IPO May 2026)
- Revenue
- ~$885M 2026 guidance (Q2 core $209.9M +103% YoY, GAAP $180.1M)
- P/E Ratio
- N/A (GAAP unprofitable, ~145x next-year est. earnings)
- P/S Ratio
- ~47.7x 2026E sales (~$885M guide), 21.40x forward P/S
- Market Cap
- $42.20B
- Net Income
- $-450.5M Q2 2026 GAAP, $1.4B accumulated deficit
- Dividend Yield
- N/A (0%)
- Short Interest
- Elevated (exact % N/A, high short volume and entrenched bear reports)
- 52-Week Low
- $160.81
- 52-Week High
- $386.34
02 · Scenario Modeling
Technical Overview
Quant overlays derived from the existing 1Y OHLCV series: trend stack, sigma bands, regression fit, drawdown regime, and a composite signal model.
RSI (14)
40.3
Momentum Stack
1M -3.6% / 3M -19.7%
Volatility Regime
70.3% 20D vol
Regression Fit
-3.0% vs trend
Drawdown Curve
Distance from rolling peak, useful for regime stress and recovery speed.
-42.9%
Trend Regime
neutral
Mixed stack
Composite Signal
bearish
Bearish (-3)
Mean Reversion
bearish
-1.89 sigma
Breakout Status
neutral
Inside channel
Range Percentile
bearish
7th pct
Volume Impulse
bullish
2.15x 20D avg
Quant Dashboard
A compact read on trend persistence, stretch, realized risk, and breakout behavior.
- 1M Return
- -3.6%
- 6M Return
- N/A
- 1Y Return
- N/A
- ATR (14)
- $11.66
- 20D Vol
- 70.3%
- 60D Vol
- 106.3%
- Regression R²
- 0.33
- Price Z-Score
- -1.89
- 52W High
- $386.34
- 52W Low
- $160.81
- Range Position
- 7th pct
- Latest Volume
- 13.9M
04 · Research
Micro Analysis
Fundamentals show explosive YoY growth masking stalling sequential momentum, collapsing profitability, and extreme customer and balance-sheet execution risk.
RPO mirage vs. recognized revenue
$25.4B RPO sounds transformative, but Q2 GAAP revenue was only $180.1M (down from $193.4M in Q1 on warrant amortization) and core revenue $209.9M. Q3 guide $214-216M implies 2-3% QoQ growth. At ~$850M annualized run-rate, RPO is 30x revenue, raising serious doubts about timing, capacity constraints, incentive pricing, and OpenAI's ability/willingness to deploy on schedule.
Extreme concentration and customer leverage
Top 3 customers = 76% of revenue; OpenAI alone = ~80% of backlog via $20B+ multiyear deal. Reports note OpenAI holds an option to acquire equity / favorable terms. This is not diversified demand — it is single-counterparty risk where pricing, timing, and technology shifts by OpenAI dictate Cerebras' fate, while competing directly with NVIDIA, AMD, and hyperscaler custom silicon.
Margin compression and cash burn
Q2 GAAP net loss $450.5M, $1.4B accumulated deficit, gross margin 40.6% falling to 38-40% in Q3, operating margin -25% to -23% trending to -30% for 2026, FCF -$680M TTM. Pivot to building/owning datacenters and renting back capacity to meet OpenAI commitments pressures near-term margins. Management promises 60%+ long-term, but that requires 10x manufacturing scale and billions in capex after a $5.55B IPO raise.
Absurd valuation after 54% drawdown
$42.2B market cap on $880-890M guided 2026 revenue = ~47-48x sales, 21.4x forward P/S, 16.9x FY27 revenue, ~145x next year's estimated earnings. Even bull-side models needing $3B revenue by 2027 and $8B by 2028 and $3.19 EPS on 75x multiple to justify $239 target prove the point: profitability is years away and priced as if flawless. Weiss D- Sell, multiple Seeking Alpha Sells, and Hold ratings reflect this.
Post-IPO overhang and dilution risk
Largest tech IPO of 2026 in May, stock down 37-52% since, lockup expiration looming, $450M quarterly losses requiring continuous funding. History shows high-burn semis fund capacity with secondary offerings. Any delay in OpenAI revenue recognition forces dilutive raises, pressuring a stock already down 19% in 3 months with elevated short activity.
04 · Research
Macro Analysis
AI infrastructure spend remains strong, but the cycle is shifting from training to cost-efficient inference, favoring incumbents with scale, while capital markets are less tolerant of cash-burn growth.
AI inference supercycle — real but hyper-competitive
Inference market seen at $292B by 2029, hyperscaler capex robust. Cerebras' speed advantage (powering OpenAI GPT-5.6 Sol ultrafast mode) is real, but NVIDIA's CUDA moat, AMD, Broadcom custom TPUs, Groq/Cerebras peers, and in-house OpenAI/Google/Amazon chips are advancing rapidly. WSE-3 memory bandwidth lead is narrow and must be defended with continuous fab investment at TSMC.
Tightening tolerance for unprofitable AI capex
After blockbuster IPO, investors punished Q1 94% growth and Q2 103% growth with -12% and -16% selloffs because losses widened. Market is rotating from revenue-multiple to cash-flow and ROIC discipline. With rates still restrictive and AI monetization questioned, 47x sales burn stories de-rate fastest, as seen in CoreWeave volatility and AI momentum slowdown noted by Motley Fool.
Supply chain and power constraints
Wafer-scale requires whole-wafer yields, advanced packaging, massive power/cooling. Cerebras must 10x manufacturing and secure datacenter power at a time of transformer shortages and utility bottlenecks. Renting capacity near-term crushes margins; owning requires billions ahead of revenue, amplifying cyclicality if AI deployment pauses.
Geopolitical and customer funding risk
Majority revenue USA, partnership with G42 (UAE) and OpenAI funding dependent on continued private fundraising. Any export controls, AI regulation, or OpenAI funding stress directly hits 80% of backlog. Concentration in one well-funded but cash-burning lab is macro-fragile.
05 · Growth
Untapped Revenue Opportunities
OpenAI $20B deployment ramp
highIf OpenAI deploys Stargate-scale inference on Cerebras wafer clusters on schedule, core cloud revenue could jump from ~$210M quarterly to multi-billion annual run-rate by 2027-2028, with bull models citing $8B by 2028 and $20B pipeline. Wedbush praise for GPT-5.6 Sol shows technical validation.
AWS marketplace and enterprise inference cloud
highAWS partnership distributes Cerebras inference to enterprises without on-prem buys. Inference cloud already up 281-300% YoY. If disaggregated inference and PyTorch simplicity win developers from NVIDIA H100/B200 rentals, high-margin recurring cloud mix could lift gross margins back to 60%+.
On-prem supercomputers and sovereign deals
mediumG42 multi-billion deal and sovereign AI demand for wafer-scale systems offer lumpy hardware sales ($510M revenue base, 76% growth cited). Additional sovereign or hyperscaler wins would diversify beyond OpenAI and accelerate RPO conversion.
06 · Catalysts
Headwinds & Tailwinds
↓ Headwinds
Single-customer dependency
high76% revenue from top 3, 80% backlog from OpenAI. Loss, delay, renegotiation, or OpenAI insourcing would erase growth story. Warrant amortization already caused GAAP sequential decline, showing accounting drag from customer incentives.
Persistent losses and dilution
high$450.5M Q2 GAAP loss, -$680M FCF, $1.4B deficit, -30% operating margin guide. Building own datacenters demands sustained capex. Lockup expiry plus likely secondaries create structural supply of shares.
NVIDIA and hyperscaler competition
highNVIDIA CUDA ecosystem, AMD MI-series, custom ASICs, and Groq inference speed competition limit pricing power. Forced incentive pricing and renting capacity signal weak near-term leverage despite benchmark wins.
RPO conversion credibility
mediumManagement guides $214-216M Q3 vs $25.4B RPO — market doubts timing. If recognition pushes to 2028+, forward multiples collapse and 145x earnings never materializes, triggering further 30-50% de-rating.
↑ Tailwinds
Differentiated wafer-scale moat
highWorld's largest chip, whole-wafer WSE-3, 150 patents, unobtainable inference speeds difficult to replicate. Validated by OpenAI and AWS, providing genuine technological edge in memory-bandwidth-bound inference.
Hypergrowth with improving core metrics
medium103% core growth, 94-76% YoY prints, inference cloud nearly 4x, positive adjusted EBITDA swing in Q1, gross margin gains earlier indicating some pricing power before capacity-rental drag.
Fortress post-IPO balance sheet
medium$5.55B IPO proceeds, low debt 0.1x D/E, 5.8x current ratio, interest income supports burn. Cash buys time to build capacity without immediate distress, enabling oversold bounce and short-covering rallies.
07 · TL;DR
Analysis Summary
- Ticker
- CBRS
- Company
- Cerebras Systems Inc. Class A Common Stock
- Analysis Date
- 2026-10-01
- Price at Analysis
- $177.65
- Rating
- Sell
- 1Y Price Target
- $125.00
- 3Y Price Target
- $140.00
- Market Cap
- $42.20B
- P/E Ratio
- N/A (GAAP unprofitable, ~145x next-year est. earnings)
This analysis was generated on 2026-10-01 when CBRS was trading at $177.65. The base-case 1-year price target is $125.00 (-29.6% implied return). Scenario range: $60.00 (hyper bear) to $320.00 (hyper bull).